Shenzhen Bioeasy Biotechnology Co. Ltd. - Asset Resilience Ratio

Latest as of March 2026: 12.61%

Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) has an Asset Resilience Ratio of 12.61% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥187.64 Million

≈ $27.46 Million USD Cash + Short-term Investments

Total Assets

CN¥1.49 Billion

≈ $217.74 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how Shenzhen Bioeasy Biotechnology Co. Ltd.'s Asset Resilience Ratio has changed over time. Check Shenzhen Bioeasy Biotechnology Co. Ltd. strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Shenzhen Bioeasy Biotechnology Co. Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Shenzhen Bioeasy Biotechnology Co. Ltd. market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥187.64 Million	12.61%
Total Liquid Assets	CN¥187.64 Million	12.61%

Asset Resilience Insights

Moderate Liquidity: Shenzhen Bioeasy Biotechnology Co. Ltd. has 12.61% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Shenzhen Bioeasy Biotechnology Co. Ltd. Industry Peers by Asset Resilience Ratio

Compare Shenzhen Bioeasy Biotechnology Co. Ltd.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	0.05%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Syndax Pharmaceuticals Inc NASDAQ:SNDX	Biotechnology	46.79%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	63.47%
Chengdu Kanghua Biological Products SHE:300841	Biotechnology	1.19%
Jiangsu Aidea Pharmaceutical Co Ltd SHG:688488	Biotechnology	4.35%

Annual Asset Resilience Ratio for Shenzhen Bioeasy Biotechnology Co. Ltd. (2019–2025)

The table below shows the annual Asset Resilience Ratio data for Shenzhen Bioeasy Biotechnology Co. Ltd..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	15.43%	CN¥235.30 Million ≈ $34.43 Million	CN¥1.52 Billion ≈ $223.09 Million	-5.35pp
2024-12-31	20.79%	CN¥302.92 Million ≈ $44.33 Million	CN¥1.46 Billion ≈ $213.23 Million	+11.94pp
2023-12-31	8.85%	CN¥120.03 Million ≈ $17.56 Million	CN¥1.36 Billion ≈ $198.48 Million	-20.67pp
2021-12-31	29.52%	CN¥340.21 Million ≈ $49.78 Million	CN¥1.15 Billion ≈ $168.65 Million	+26.29pp
2019-12-31	3.23%	CN¥20.00 Million ≈ $2.93 Million	CN¥619.67 Million ≈ $90.68 Million	--

pp = percentage points

About Shenzhen Bioeasy Biotechnology Co. Ltd.

SHE:300942 China Biotechnology

Market Cap

$377.59 Million

CN¥2.58 Billion CNY

Market Cap Rank

#13604 Global

#4022 in China

Share Price

CN¥6.37

Change (1 day)

+2.25%

52-Week Range

CN¥5.71 - CN¥13.82

All Time High

CN¥40.28